483
Lexenpharm (Suzhou) LimitedFDA 483 - Lexenpharm (Suzhou) Limited - September 04, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Lexenpharm (Suzhou) Limited, a sterile drug manufacturer, received an FDA Form 483 for significant deficiencies in laboratory record-keeping. Inspectors observed torn and discarded balance printouts and other GMP records in the QC laboratory, indicating a failure to maintain complete data and adhere to established documentation procedures. This raises concerns about data integrity and compliance with good manufacturing practices.
Open in Dashboard
ID · d6565661-53d5-4b5b-8dde-780300a49937